col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


37 Results       Page 1

 [1] 
Elsevier: Arabian Journal of Chemistry
  original article Date Title Authors   All Authors
1 [GO] 2024―Jul―28 Exploring the therapeutic efficacy: Unveiling the active compounds of Huashi Baidu granules against COVID-19 Chuanxi Tian, Jinyue Zhao, Qian Wang, Keke Luo, Shuang Zhao, Li Wan, et al. (+4)
2 [GO] 2024―Mar―08 Characterization of polycyclic aromatic hydrocarbon from open burning of disposable COVID-19 facemask: Spatial distribution and risk assessment Olusola Adedayo Adesina, Raymond Opara, Biodun Adewale, Lala Mayowa, Jacob Sonibare
3 [GO] 2024―Jan―24 Deciphering the potential therapeutic targets and mechanisms of jaranol for the treatment of COVID-19 and lung adenocarcinoma Zhongcui Kang, Qian Wu, Qihang Peng, Yiting Deng, Hongxia Xu, Yu Xiao, et al. (+4)
4 [GO] 2024―Jan―09 First report on the QSAR modelling and multistep virtual screening of the inhibitors of nonstructural protein Nsp14 of SARS-CoV-2: reducing unnecessary chemical synthesis and experimental tests Qianqian Wang, Tengjiao Fan, Runqing Jia, Na Zhang, Lijiao Zhao, Rugang Zhong, Guohui Sun
5 [GO] 2023―Dec―28 Design of new dipeptide inhibitors against SARS-CoV 3CLpro: 3D-QSAR, molecular docking, MD simulation, ADMET studies and retrosynthesis strategy Esslali Soukaina, Liman Wissal, Koubi Yassine, El Allali Achraf, Farhate Guenoun, Mohammed Bouachrine
6 [GO] 2023―Dec―07 Deciphering the mechanism of Ephedra Herba-Armeniacae Semen Amarum herb pairs on COVID-19 by integrated network pharmacology and bioinformatics Zhuoxi Wang, Jifang Ban, He Wang, Rui Qie, Yabin Zhou
7 [GO] 2023―Nov―28 Potential inhibition of SARS-CoV-2 infection and its mutation with the novel Geldanamycin analogue: Ignaciomycin Antony Stalin, Pachaiyappan Saravana Kumar, Balakrishnan Senthamarai Kannan, Rajamanikam Saravanan, Savarimuthu Ignacimuthu, Quan Zou
8 [GO] 2023―Oct―27 Synthesis, In Silico and In Vitro Studies of Novel Quinazolinone Derivatives as Potential SARS-CoV-2 3CLpro Inhibitors Mubarak A. Alamri, Obaid Afzal, Md Jawaid Akhtar, Shahid Karim, Mohammed Husain, Manal A. Alossaimi, Yassine Riadi
9 [GO] 2023―Oct―20 Computational screening of potential bromodomain-containing protein 2 inhibitors for blocking SARS-CoV-2 infection through pharmacophore modeling, molecular docking and molecular dynamics simulation Shaohua Xu, Huicheng Yuan, Ling Li, Kai Yang, Liangcun Zhao
10 [GO] 2023―Sep―25 From ancient remedy to modern medicine: Artemisia argyi sesquiterpenoids as a promising natural treatment for COVID-19 Yujing Huang, Zhilin Huang, YuHui Gan, Juntao Xie, Zhiyun Xia, Liu Tao, et al. (+7)
11 [GO] 2023―Jun―08 A suitable drug structure for interaction with SARS-CoV-2 main protease between Boceprevir, Masitinib and Rupintrivir; a molecular dynamics study Mehdi Yoosefian, Razieh Dashti, Mohamad Mahani, Leila Montazer, Amirabbas Mir
12 [GO] 2023―May―18 Screening compounds for treating the diabetes and COVID-19 from Miao medicine by molecular docking and bioinformatics Feng Xu, Xulong Huang, Hongmei Wu, Xiangpei Wang
13 [GO] 2023―May―17 Identification of Potential Indonesian Marine Invertebrate Bioactive Compounds as TMPRSS2 and SARS-CoV-2 Omicron Spike Protein Inhibitors through Computational Screening Haviani Rizka Nurcahyaningtyas, Alfrina Irene, Joko Tri Wibowo, Masteria Yunovilsa Putra, Arry Yanuar
14 [GO] 2023―Apr―28 Compounds from Myrtle Flowers as Antibacterial Agents and SARS-CoV-2 Inhibitors: In-vitro and Molecular Docking Studies Badra Barhouchi, Rafik Menacer, Saad Bouchkioua, Amira Mansour, Nadjah Belattar
15 [GO] 2023―Mar―06 Unraveling the mechanism of action of cepharanthine for the treatment of novel coronavirus pneumonia (COVID-19) from the perspectives of systematic pharmacology Feifei Sun, Jinde Liu, Ali Tariq, Zhonglei Wang, Yongning Wu, Lin Li
16 [GO] 2023―Feb―15 COVID-19 Chloroquine Drug Detection Using Novel, Highly Sensitive SnO2-Based Electrochemical Sensor Ayman AbdelHamid, Abdelaziz Elgamouz, Monther Khanfer, Abdel-Nasser Kawde
17 [GO] 2023―Feb―08 In silico study of Novel Niclosamide Derivatives, SARS-CoV-2 nonstructural proteins catalytic residue-targeting small molecules drug candidates Bashir Lawal, Sheng-Kuang Tsai, Alexander T.H Wu, Hsu-Shan Huang
18 [GO] 2022―Nov―30 Chloroquine Chaos and COVID-19: Smart delivery perspectives through pH sensitive polymers/ micelles and ZnO nanoparticles Anju Manuja, Balvinder Kumar, Dharvi Chhabra
19 [GO] 2022―Oct―19 Microwave Assisted Synthesis of 2-amino-4-chloro-pyrimidine Derivatives: Anticancer and Computational Study on Potential Inhibitory Action against COVID-19 Faiza Qureshi, Muhammad Nawaz, Soleiman Hisaindee, Sarah Ameen Almofty, Mohammad Azam Ansari, Qazi Mohammad Sajid Jamal, et al. (+5)
20 [GO] 2022―Oct―12 Pharmacophore model-aided virtual screening combined with comparative molecular docking and molecular dynamics for identification of marine natural products as SARS-CoV-2 papain-like protease inhibitors Neelaveni Thangavel, Mohammed Albratty
21 [GO] 2022―Sep―15 One-pot synthesis, X-ray crystal structure, and identification of potential molecules against COVID-19 main protease through structure-guided modeling and simulation approach Youness El Bakri, Malahat Musrat Kurbanova, Sabir Ali Siddique, Sajjad Ahmad, Souraya Goumri-Said
22 [GO] 2022―Aug―06 Ecofriendly and sustainable Sargassum spp.-based system for the removal of highly used drugs during the COVID-19 pandemic J. Luis López-Miranda, Gustavo A. Molina, Rodrigo Esparza, Marlen Alexis González-Reyna, Rodolfo Silva, Miriam Estévez
23 [GO] 2022―Jul―11 Synthesis and Greener Pastures Biological Study of Bis-thiadiazoles as Potential Covid-19 Drug Candidates Musa A. Said, Sayed M. Riyadh, Nadia S. Al-Kaff, A.A. Nayl, Khaled D. Khalil, Stefan Bräse, Sobhi M. Gomha
24 [GO] 2022―May―31 Fluorescence spectrophotometry for COVID-19 determination in clinical swab samples Kartika A. Madurani, Suprapto Suprapto, Muhammad Yudha Syahputra, Ika Puspita, Abdul Hadi Furqoni, Listya Puspasari, et al. (+6)
25 [GO] 2022―Apr―27 Prediction of COVID-19 manipulation by selective ACE inhibitory compounds of Potentilla reptant root: In silico study and ADMET profile Yuan Xu, Mahmood Al-Mualm, Ermias Mergia Terefe, Maksuda Ilyasovna Shamsutdinova, Maria Jade Catalan Opulencia, Fahad Alsaikhan, et al. (+9)
26 [GO] 2021―Dec―10 Development of superior antibodies against the S-protein of SARS-Cov-2 using macrocyclic epitopes Hassan Traboulsi, Mohammed A. Khedr, Rafea Elgorashe, Yasair Al-Faiyz, Amr Negm
27 [GO] 2021―Dec―01 Computational Screening and Biochemical Analysis of Pistacia Integerrima and Pandanus Odorifer Plants To Find Effective Inhibitors Against Receptor-Binding Domain (RBD) of the Spike Protein of SARS-Cov-2 Gobindo Kumar Paul, Shafi Mahmud, Afaf A Aldahish, Mirola Afroze, Suvro Biswas, Swagota Briti Ray Gupta, et al. (+8)
28 [GO] 2021―Nov―28 A possible Potential COVID-19 Drug Candidate: Diethyl 2-(2-(2-(3-methyl-2-oxoquinoxalin-1(2H)-yl)acetyl)hydrazono)malonate: Docking of Disordered Independent Molecules of a Novel Crystal Structure, HSA/DFT/XRD and cytotoxicity Mohcine Missioui, Musa A. Said, Güneş Demirtaş, Joel T. Mague, Ahlam Al-Sulami, Nadia S. Al-Kaff, Youssef Ramli
29 [GO] 2021―Aug―23 Potential bioactive compounds as SARS-COV-2 inhibitors from extracts of the marine red alga Halymenia durvillei (Rhodophyta) - A computational study Asmi Citra Malina A.R. Tassakka, Ophirtus Sumule, Muhammad Nasrum Massi, Marianti Manggau, Israini Wiyulanda Iskandar, Jamaluddin Fitrah Alam, et al. (+2)
30 [GO] 2021―Aug―16 Scoping Insight on Antiviral Drugs Against COVID-19 Ahmed S Ali, Ibrahim M Ibrahim, Abdulhadi S Burzangi, Ragia H. Ghoneim, Hanin S Aljohani, Hamoud A Alsamhan, Jehan Barakat
31 [GO] 2021―Jul―28 Exploring the interaction of quercetin-3-O-sophoroside with SARS-CoV-2 main proteins by theoretical studies: a probable prelude to control some variants of coronavirus including Delta Suliman Khan, Arif Hussain, Yasaman Vahdani, Hamideh Kooshki, Bashdar Mahmud Hussen, Setareh Haghighat, et al. (+13)
32 [GO] 2021―Jul―14 Antiviral peptides against the main protease of SARS-CoV-2: A molecular docking and dynamics study Shafi Mahmud, Suvro Biswas, Gobindo Kumar Paul, Mohasana Akter Mita, Shamima Afrose, Md. Robiul Hasan, et al. (+8)
33 [GO] 2021―Jun―08 Quantitative Structure-Property Relationships (QSPR) of Valency Based Topological Indices with Covid-19 drugs and Application Jian-Feng Zhong, Abdul Rauf, Muhammad Naeem, Jafer Rahman, Adnan Aslam
34 [GO] 2021―Feb―25 Structure- and Ligand-Based In silico Studies toward the Repurposing of Marine Bioactive Compounds to Target SARS-CoV-2 Marwa A.A. Fayed, Mohammed Farrag El-Behairy, Inas A. Abdallah, Hend Mohamed Abdel-Bar, Hanan Elimam, Ahmed Mostafa, et al. (+3)
35 [GO] 2021―Jan―12 Pharmacological basis for the potential role of Azithromycin and Doxycycline in management of COVID-19 Ahmed S. Ali, Mai A. ASattar, Shahed Kareem, Dina Kutbi, Hanin Aljohani, Duaa Bakhshwin, et al. (+2)
36 [GO] 2020―Oct―01 TAT-peptide conjugated repurposing drug against SARS-CoV-2 main protease (3CLpro): potential therapeutic intervention to combat COVID-19 Mohammad Azam Ansari, Qazi Mohammad Sajid Jamal, Suriya Rehman, Ahmad Almatroudi, Mohammad A. Alzohairy, Mohammad N. Alomary, et al. (+5)
37 [GO] 2020―Aug―09 Structure-based virtual screening and molecular dynamics of phytochemicals derived from Saudi medicinal plants to identify potential COVID-19 therapeutics Mubarak A. Alamri, Ali Altharawi, Alhumaidi B. Alabbas, Manal A. Alossaimi, Safar M. Alqahtani
 [1] 

37 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec